ADC cytotoxins, also referred to as payloads, are cytotoxic substances that cause the death of target cells in ADCs (antibody drug conjugates). A monoclonal antibody, a linker, and a cytotoxin are the components of an ADC, which is a targeted agent. The cytotoxin is the most crucial component because it determines how effective an ADC is at killing cancer cells.
Numerous cytotoxins, including calicheamicins, duocarmycins, pyrrolobenzodiazepines (PBDs), camptothecins, daunorubicins/doxorubicins, auristatins, and maytansinoids, are currently in use. Based on how they work, they can be classified as either DNA-damaging agents or tubulin inhibitors. Among them are DNA minor groove binders like Calicheamicins, Duocarmycins, and PBDs as well as topoisomerase inhibitors like Camptothecins and Daunorubicins/Doxorubicins, which damage DNA. Tubulin inhibitors include auristatins and maytansinoids. There are numerous conventional cytotoxic agents with comparable mechanisms of killing cancer cells that can also be used in the development of ADCs in addition to the listed cytotoxins.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V93026 | Glucocorticoid receptor agonist-5 | 2913231-72-6 | Glucocorticoid receptor agonist-5 (compound 4) is a glucocorticoid molecule and a potent glucocorticoid receptor agonist. |
|
V54474 | Gly-Cyclopropane-Exatecan | 2414254-49-0 | Gly-Cyclopropane-Exatecan (compound 5c) participates in the synthesis/preparation of anti-B7-H4 antibody active molecular conjugates (ADC), containing the DNA topoisomerase I (Top I) inhibitor Exatecan . |
|
V99943 | Gly-Gly-Phe-Gly-NH-O-CO-Exatecan | 1599440-12-6 | Gly-Gly-Phe-Gly-NH-O-CO-Exatecan is an ADC toxin. |
|
V54487 | Hemiasterlin derivative-1 | 1887046-60-7 | Hemiasterlin analogue-1 is a hemiasterlin analogue. |
|
V137675 | Hydrotecan | 2694026-68-9 | Hydrotecan is a camptothecin derivative that can be used as an antibody-drug conjugate (ADC) cytotoxic agent. |
|
V51961 | Hygrolidin | 83329-73-1 | Hygrolidin is a 16-membered macrolide antibiotic derived from Streptomyces hygroscopicus D-1166. |
|
V53423 | Luisol A | 225110-59-8 | Luisol A is an aromatic tetraol that is the major metabolite of estuarine marine actinomycetes of the genus Streptomyces. |
|
V51807 | Maytansinoid B | 1628543-40-7 | Maytansinoid B is an ADC Cytotoxin that can be coupled with antibodies to form Antibody-Drug Conjugates (ADCs). |
|
V100024 | MMAF-methyl ester | 2353409-70-6 | MMAF-methyl ester is an ADC toxin. |
|
V29041 | MMAF-OMe | 863971-12-4 | MMAF-OMe (Monomethyl auristatin F methyl ester-O-methyl), an auristatin-derived anticancer agent, is a novel and potent warhead used in ADC (antibody-drug conjugate). |
|
V88353 | MMAF-OtBu | 745017-95-2 | MMAF-OtBu ( Example 2) is a modified MMAF. |
|
V51229 | Modified MMAF | 1352202-47-1 | ADC cytotoxin |
|
V41147 | Muscotoxin A | 1653999-47-3 | Muscotoxin A is ADC cytotoxin. |
|
V85199 | Mycobacterium Tuberculosis-IN-2 | 2284580-65-8 | |
|
V88355 | MYX1715 | 2445448-66-6 | MYX1715 is an inhibitor of N-myristoyltransferase (NMT) with a KD of 0.09 nM. |
|
V102480 | N-Ac-γ-Calicheamicin-AcBut-NHS ester | 174885-02-0 | AcBut-N-Ac-γ-Calicheamicin is an ADC toxic molecule that induces cell cycle arrest and apoptosis by inducing DNA double-strand breaks. |
|
V37613 | N-Me-L-Ala-maytansinol | 77668-69-0 | N-Me-La L a-maytansinol is a hydrophobic, cell-penetrating/penetrable payload for the preparation of active antibody conjugates (ADCs). |
|
V25076 | Maytansinoid DM4 | 796073-69-3 | Maytansinoid DM4, a naturally occuring maytansine analogue, is a highly potent/cytotoxic antitubulin agent with anticancer properties. |
|
V54472 | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT | 2857037-69-3 | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) is a topoisomerase I inhibitor that can be targeted and delivered to cells through conjugated antibodies and has good ADC activity in vivo and in vitro. |
|
V76704 | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT hydrochloride | NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT(compound I) HCl is a topoisomerase I inhibitor that can be targeted and delivered to cells through conjugated antibodies and has good in vitro and in vivo ADC activity. |